Clinical trial
Clinical Trial Studying a Personalized Cancer Vaccine in Patients With…
NCT00126178 · Agenus Inc., Industry · Terminated
Key facts
| NCT number | NCT00126178 |
|---|---|
| Title | Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer |
| Official title | A Multi-Center, Randomized, Phase 3 Study of Adjuvant Oncophage® Versus Observation in Patients With High Risk After Surgical Treatment for Renal Cell Carcinoma |
| Lead sponsor | Agenus Inc., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Cancer, Renal Cell Carcinoma |
| Intervention type | Biological |
| Interventions | HSPPC-96 |
| Enrollment | 600 |
| Start date | May 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Aug 3, 2005 |
| Last update posted | Sep 7, 2012 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: